Cartesian Therapeutics (RNAC) EBIT Margin Growth (3y) (2018 - 2026)
Cartesian Therapeutics (RNAC) EBIT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | -623.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 6,993.00 |
| 10 | Cartesian Therapeutics | 214.57 Mn | 214.57 Mn | - | -3.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.37 Mn |
| Dec 31, 2025 | -825,343.00 |
| Mar 31, 2025 | -202,160.00 |
| Dec 31, 2024 | 318,387.00 |
| Jun 30, 2024 | 3,905.00 |
| Mar 31, 2024 | -16,378.00 |
| Dec 31, 2023 | -37,345.00 |
| Sep 30, 2023 | 9,617.00 |
| Dec 31, 2022 | 13,832.00 |
| Jun 30, 2022 | 12.49 Mn |
| Mar 31, 2022 | 11.86 Mn |
| Dec 31, 2021 | 161,927.00 |
| Dec 31, 2020 | 11.33 Mn |
| Sep 30, 2020 | 5.10 Mn |
| Dec 31, 2019 | 28,413.00 |
| Jun 30, 2019 | -12.46 Mn |
| Mar 31, 2019 | -11.82 Mn |
| Dec 31, 2018 | -127,261.00 |